Our findings suggest the YAP/TAZ‐mTORC1‐ATF4 axis as a potential therapeutic target for human fibrotic lung diseases such as BO by modulating the differentiation program of secretory or DATP cells in PF lungs. This evidence concerns the gene ATF4 and pemphigus foliaceus.